Treatment of Schizophrenic Patients With Ziprasidone
Information source: Pfizer
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Schizophrenia
Intervention: Ziprasidone (Drug)
Phase: N/A
Status: Completed
Sponsored by: Pfizer Official(s) and/or principal investigator(s): Pfizer CT.gov Call Center, Study Director, Affiliation: Pfizer
Summary
To determine whether ziprasidone provides good efficacy and tolerability in the treatment of
schizophrenic Greek patients.
Clinical Details
Official title: Treatment of Schizophrenic Patients With Geodon; Capsules/Oral Suspension/Solution for Injection (Ziprasidone)
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Summary of SchizophreniaSummary of Metabolic Risk Factors Summary of Most Frequently Used Concomitant Drug Treatments
Secondary outcome: Number of Participants With Categorical Scores on Clinical Global Impression - Improvement (CGI-I)Number of Participants With Categorical Scores on Clinical Global Impression of Severity (CGI-S) Positive and Negative Syndrome Scale (PANSS) - Positive Subscale PANSS - Negative Subscale PANSS - Composite Subscale Number of Participants Answering the Question "How Satisfied or Dissatisfied Are You With the Ability of the Medication to Prevent or Treat Your Condition?" Number of Participants Answering the Question "How Satisfied or Dissatisfied Are You With the Way the Medication Relieves Your Symptoms?" Number of Participants Answering the Question "How Satisfied or Dissatisfied Are You With the Amount of Time it Takes the Medication to Start Working?" Number of Participants Answering the Question "As a Result of Taking This Medication, do You Experience Any Side Effects at All?" Number of Participants Answering the Question "How Bothersome Are the Side Effects of the Medication You Take to Treat Your Condition?" Number of Participants Answering the Question "To What Extent do the Side Effects Interfere With Your Physical Health and Ability to Function (ie, Ability to Think Clearly, Stay Awake, Etc)?" Number of Participants Answering the Question "To What Extent do the Side Effects Interfere With Your Mental Function (ie, Ability to Think, Stay Awake, Etc)?" Number of Participants Answering the Question "To What Degree Have Medication Side Effects Affected Your Overall Satisfaction With the Medication?" Number of Participants Answering the Question "How Easy or Difficult is it to Use the Medication in Its Current Form?" Number of Participants Answering the Question "How Easy or Difficult is it to Plan When You Will Use the Medication Each Time?" Number of Participants Answering the Question "How Convenient or Inconvenient is it to Take the Medication as Instructed?" Number of Participants Answering the Question "Overall, How Confident Are You That Taking This Medication is a Good Thing?" Number of Participants Answering the Question "How Certain Are You That the Good Things About Your Medication Outweigh the Bad Things?" Number of Participants Answering the Question "Taking All Things Into Account, How Satisfied or Dissatisfied Are You With This Medication?" Percent Change From Baseline to Final Visit in Body Weight
Detailed description:
Sampling Method Details: Non-interventional study (subjects chosen by physician in
accordance to their usual practice).
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Usual clinical practice of physician
Exclusion Criteria:
- None
Locations and Contacts
Pfizer Investigational Site, Athens 12461, Greece
Pfizer Investigational Site, Chaidari 124 61, Greece
Pfizer Investigational Site, Chaidari 12461, Greece
Pfizer Investigational Site, Chaidari 12462, Greece
Pfizer Investigational Site, Corfu 49100, Greece
Pfizer Investigational Site, Crete 731-00, Greece
Pfizer Investigational Site, Giannitsa 58100, Greece
Pfizer Investigational Site, Haidari 12461, Greece
Pfizer Investigational Site, Kalamata 24100, Greece
Pfizer Investigational Site, Katerini 60100, Greece
Pfizer Investigational Site, Kozani 50100, Greece
Pfizer Investigational Site, Kozani, Greece
Pfizer Investigational Site, Lamia 35100, Greece
Pfizer Investigational Site, Larisa, Greece
Pfizer Investigational Site, Patra 26001, Greece
Pfizer Investigational Site, Patra 26000, Greece
Pfizer Investigational Site, Thessaloniki 564-29, Greece
Pfizer Investigational Site, Thessaloniki 56430, Greece
Pfizer Investigational Site, Thessaloniki 57010, Greece
Pfizer Investigational Site, Volos 38222, Greece
Additional Information
To obtain contact information for a study center near you, click here.
Starting date: October 2007
Last updated: September 16, 2010
|